An interventional study of Ginseng and Placebo in Mental Acuity, sponsored by Arizona State University. Recruiting at 1 site in United States. Open to participants aged 18 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-06.
Sponsored by Arizona State University · Not applicable, Interventional, and Basic science
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 654 studies in Psychological Well-Being with a site in United States — 187 open to participants now, 239 under way, 1 of them phase 3. Psychological Well-Being · United States.
Among the 654 studies in Psychological Well-Being with a site in United States, this one is the 476th largest by planned enrollment of the 572 interventional ones that give a count, is one of 84 that started in 2026, is one of 514 with no phase, reaches primary completion later than 71 of the 237 other live ones, and was the 618th registered.
2,208 studies on the registry are indexed under Psychological Well-Being; 730 are open to participants now.
Browse Psychological Well-Being studies →187 of the 654 studies in Psychological Well-Being with a site in United States are open now. Recruiting first, the newest first:
Columbia University · Sites in United States
Ages 12–80
Chestnut Health Systems · Sites in United States
Ages 18+ · Healthy volunteers
University of Massachusetts, Worcester · Sites in United States
Ages 18+
Beth Israel Deaconess Medical Center · Sites in United States
Ages 18–40 · Healthy volunteers
University of South Carolina · Sites in United States
Ages 18+ · Women only
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 403 Psychological Well-Being studies recruiting now, 223 (55%) set no upper age limit and 155 (38%) stop at 75 or younger; 121 take children under 18; 206 take healthy volunteers.
This study: 18 Years to 30 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
654 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 20 · Phase 2 29 · Phase 3 10 · Phase 4 6
First in 1996; this study’s year is marked. 84 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 30 is below the median of 110 across 1,808 interventional studies indexed under Psychological Well-Being.
Median enrollment 116 across the 572 interventional studies, 500 across the 81 observational. Of the 383 that completed or were terminated, 120 (31%) have results posted.
This tab as a report to print or save as PDF → With an account.
53 of 654 have an industry lead sponsor. The 10 most frequent:
Arizona State University is the lead sponsor of 239 studies on the registry; 43 are open to participants now.
Arizona State University has 5 studies filed under Psychological Well-Being — fewer than ten, so there is no comparison to draw.
99 of the studies in Psychological Well-Being with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07011459Tulane UniversityThe Cooking for Health Optimization and Disease Prevention (CHOP) Trial | 2026-11 |
| NCT07718646Oklahoma State UniversityMobile Health Coping Intervention for Mothers Experiencing Food Insecurity | 2026-11 |
| NCT06915259University of PennsylvaniaDoula Model of Care | 2026-11 |
| NCT04833829Emory UniversityCross-disciplinary HIV Integrated Mental Health Support Intervention | 2026-11 |
| NCT06989593Sarah SchlegelBreaking Silence Through Story: A Narrative Medicine Intervention for Parents of Children With Urogenital Conditions | 2026-11 |
Add all 99 to your calendar (.ics) → With an account.
Among the 654 studies in Psychological Well-Being with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
College students face substantial and persistent mental health challenges that directly affect cognitive performance, stress regulation, and emotional well-being. Neurological functions such as working memory, attention regulation, executive control, and emotional processing are highly sensitive to stressors, leaving young adults vulnerable to daily fluctuations in cognitive efficiency. Recent findings from the Healthy Minds Network (2025) indicate that although rates of moderate to severe depression among college students declined from 44% in 2022 to 37% in 2025, and anxiety symptoms fell from 37% to 32%, levels of psychological flourishing also dropped, falling to 36% despite these improvements.
Ginseng contains bioactive compounds known as ginsenosides that favorably influence brain function and inflammatory cascades. Studies in stressed and moderately stressed adults demonstrated reduced perceived stress, improved emotional processing, enhanced cognitive performance, and beneficial changes to biomarkers with ginseng supplementation. In addition, randomized controlled trials reported improvements in mood regulation, fatigue resistance, and aspects of working memory and attention following short-term ginseng supplementation. This study will examine the effects of daily red panax ginseng supplementation (3000 mg/day; two 1500 mg Red Panax gummies) on cognitive performance and emotional well-being in healthy young adults.
College students face substantial and persistent mental health challenges that directly affect cognitive performance, stress regulation, and emotional well-being. Neurological functions such as working memory, attention regulation, executive control, and emotional processing are highly sensitive to stressors, leaving young adults vulnerable to daily fluctuations in cognitive efficiency. Recent findings from the Healthy Minds Network (2025) indicate that although rates of moderate to severe depression among college students declined from 44% in 2022 to 37% in 2025, and anxiety symptoms fell from 37% to 32%, levels of psychological flourishing also dropped, falling to 36% despite these improvements.
Ginseng contains bioactive compounds known as ginsenosides that favorably influence multiple neurobiological pathways such as neurotrophic signaling, neurotransmitter regulation, oxidative balance, and inflammatory cascades. Studies in stressed and moderately stressed adults demonstrated reduced perceived stress, improved emotional processing, enhanced cognitive performance, and modulated biomarkers related to the hypothalamic-pituitary-adrenal axis with ginseng supplementation. In addition, randomized controlled trials reported improvements in mood regulation, fatigue resistance, and aspects of working memory and attention following short-term ginseng supplementation. This study will examine the effects of daily red panax ginseng supplementation (3000 mg/day; two 1500 mg Red Panax gummies) on cognitive performance and emotional well-being in healthy young adults.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
ginseng
Dietary Supplement: Ginseng
strawberry gummy (2)
Dietary Supplement: Placebo
This study will test the efficacy of ginseng on health compared to placebo treatment.
This study will test the efficacy of ginseng on health compared to placebo treatment.
cognitive performance
Trail Making Test: measures cognitive flexibility; visual attention, and executive function, with interpretation based on completion times (in seconds)
Time frame: 2 hours post ingestion
cognitive performance
Trail Making Test measures cognitive flexibility; visual attention, and executive function, with interpretation based on completion times (in seconds)
Time frame: 2 weeks
stress
Perceived Stress Scale: higher scores indicate higher stress
Time frame: 2 weeks
mental well being
Warwick-Edinburgh Mental Well-Being Scale: higher scores indicating greater positive mental wellbeing
Time frame: 2 weeks
cognitive performance
Stroop test: measures attention span, reaction time, and ability to resist distractions
Time frame: 2 hours post ingestion
cognitive performance
reaction time test: measured by the elapsed time between stimulus onset and an individual's response
Time frame: 2 hours post ingestion
Plan to share: No
No publications or documents are linked to this record.
Started Jun 2026 (actual). Primary completion is estimated for Dec 2026, 5 months after the start.
Of 1,274 non-industry interventional studies with no phase under Psychological Well-Being, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 34. This study's planned 5 months is below that.
Counting every sponsor, half of 1,317 studies reached it within 16 months; a quarter within 7 and three quarters within 34.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Asian ginseng